A Cross-Sectional Assessment of Urinary Tract Infections Among Geriatric Patients: Prevalence, Medication Regimen Complexity, and Factors Associated With Treatment Outcomes
Overview
Affiliations
Urinary tract infections (UTIs) are the second most prevalent infection among the elderly population. Hence, the current study aimed to evaluate the prevalence of UTIs among older adults, medication regimen complexity, and the factors associated with the treatment outcomes of elderly patients infected with UTIs. A retrospective cross-sectional study was conducted at the Department of Urology, Hospital Pulau Pinang, Malaysia. The patients ≥65 years of age were included in the present study with a confirmed diagnosis of UTIs from 2014 to 2018 (5 years). A total of 460 patients met the inclusion criteria and were included in the present study. Cystitis (37.6%) was the most prevalent UTI among the study population followed by asymptomatic bacteriuria (ASB) (31.9%), pyelonephritis (13.9%), urosepsis (10.2%), and prostatitis (6.4%). Unasyn (ampicillin and sulbactam) was used to treat the UTIs followed by Bactrim (trimethoprim/sulfamethoxazole), and ciprofloxacin. The factors associated with the treatment outcomes of UTIs were gender (odd ratio [] = 1.628; = 0.018), polypharmacy ( = 0.647; = 0.033), and presence of other comorbidities ( = 2.004; = 0.002) among the study population. Cystitis is the most common UTI observed in older adults. Gender, the burden of polypharmacy, and the presence of comorbidities are the factors that directly affect the treatment outcomes of UTIs among the study population.
Research progress of extracellular vesicles in the pathogenesis of type IIIA chronic prostatitis.
Cheng L, Luo P, Li W, Chen Q, Gan L, Zhang F Front Immunol. 2025; 16:1496055.
PMID: 40034709 PMC: 11873842. DOI: 10.3389/fimmu.2025.1496055.
Rapid and accurate testing for urinary tract infection: new clothes for the emperor.
Moreland R, Brubaker L, Tinawi L, Wolfe A Clin Microbiol Rev. 2024; 38(1):e0012924.
PMID: 39641639 PMC: 11905368. DOI: 10.1128/cmr.00129-24.
Al Qahtani M, Naghib M, Alshamrani A, Al Mazroua A, Alayyaf A, Ofisan S IJID Reg. 2024; 13:100469.
PMID: 39507391 PMC: 11539122. DOI: 10.1016/j.ijregi.2024.100469.
Comprehensive insights into UTIs: from pathophysiology to precision diagnosis and management.
Sujith S, Solomon A, Rayappan J Front Cell Infect Microbiol. 2024; 14:1402941.
PMID: 39380727 PMC: 11458535. DOI: 10.3389/fcimb.2024.1402941.
Jia H, Su W, Zhang J, Wei Z, Tsikwa P, Wang Y PLoS One. 2024; 19(9):e0310903.
PMID: 39325710 PMC: 11426445. DOI: 10.1371/journal.pone.0310903.